PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32319481-0	2020	Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy.	mesoporous silica	45-62	CD44 molecule (Indian blood group)	Homo sapiens	31-35